Masimo Corp MASI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MASI is a good fit for your portfolio.
News
-
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
-
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
-
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
-
Masimo's stock gains on report of activist campaign, disclosure of spinoff plan
-
Politan Nominates Two Independent Candidates for Masimo Board
-
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
-
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
Masimo Named One of Fast Company’s Most Innovative Companies in North America
Trading Information
- Previous Close Price
- $135.28
- Day Range
- $135.55–137.72
- 52-Week Range
- $75.55–191.00
- Bid/Ask
- $136.20 / $136.65
- Market Cap
- $7.22 Bil
- Volume/Avg
- 90,957 / 511,672
Key Statistics
- Price/Earnings (Normalized)
- 40.25
- Price/Sales
- 3.57
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,800
- Website
- https://www.masimo.com
Comparables
Valuation
|
Metric
|
MASI
|
PODD
|
ARAY
|
|---|---|---|---|
Price/Earnings (Normalized) | 40.25 | 61.50 | — |
Price/Book Value | 5.24 | 15.96 | 4.62 |
Price/Sales | 3.57 | 7.26 | 0.48 |
Price/Cash Flow | 44.34 | 36.62 | 44.12 |
Price/Earnings
MASI
PODD
ARAY
Financial Strength
|
Metric
|
MASI
|
PODD
|
ARAY
|
|---|---|---|---|
Quick Ratio | 1.04 | 2.36 | 0.75 |
Current Ratio | 2.18 | 3.51 | 1.58 |
Interest Coverage | 2.69 | 6.14 | 0.08 |
Quick Ratio
MASI
PODD
ARAY
Profitability
|
Metric
|
MASI
|
PODD
|
ARAY
|
|---|---|---|---|
Return on Assets (Normalized) | 6.66% | 8.02% | −0.79% |
Return on Equity (Normalized) | 15.47% | 33.45% | −7.26% |
Return on Invested Capital (Normalized) | 10.71% | 10.07% | 2.10% |
Return on Assets
MASI
PODD
ARAY
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Shdvljn | Gqflrj | $185.4 Bil | |
SYK
| Stryker Corp | Rqspqwyh | Ggv | $128.2 Bil | |
BSX
| Boston Scientific Corp | Smzmdyzm | Vdcgsq | $107.7 Bil | |
MDT
| Medtronic PLC | Qwpfdfy | Jlfyzz | $105.2 Bil | |
DXCM
| DexCom Inc | Hfzvfcbqz | Wtqkx | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Tnzsrbcmnq | Zwlkmtq | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Xflvvmbdt | Xvpr | $24.6 Bil | |
ALGN
| Align Technology Inc | Qggzdwlfm | Gbjdcr | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Dgbsvqkb | Bsbrzh | $18.7 Bil | |
PODD
| Insulet Corp | Xwscdsxq | Wxfdrd | $11.5 Bil |